This episode with Richard Sever, co-founder of bioRxiv and medRxiv, focuses on preprints. How come they have been so widely adopted as a means of disseminating research? Which factors helped, and what made the process difficult? We also discuss the place (and time) of scientific validation in a scientific system where work is published and shared rapidly, and independently, without in-depth review.